Recruiting NA INTERVENTIONAL 1-arm NCT04691284

Microbiome in Cancer Patients With High Dose Chemotherapy With Stem Cell Transplantation (SCTMICROBIOM)

Microbiome in Cancer Patients Undergoing High Dose Chemotherapy With Stem Cell Transplantation

Sponsor: National Cancer Institute, Slovakia

Interventions Blood, urine and stool sampling

Updated 7 times since 2021 Last updated: May 22, 2025 Started: Mar 1, 2021 Primary completion: Dec 31, 2025 Completion: Dec 31, 2026

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Hematologic Neoplasms, this trial is actively recruiting participants. The trial is conducted by National Cancer Institute, Slovakia and has accumulated 7 data snapshots since 2021. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

Change History

7 versions recorded

Jun 2025 — Present [monthly]

Recruiting NA
Sep 2024 — Jun 2025 [monthly]

Recruiting NA
Jul 2024 — Sep 2024 [monthly]

Recruiting NA
Nov 2023 — Jul 2024 [monthly]

Recruiting NA
Apr 2021 — Nov 2023 [monthly]

Recruiting NA

Status: Not Yet Recruiting → Recruiting

▶ Show 2 earlier versions

Feb 2021 — Apr 2021 [monthly]

Not Yet Recruiting NA
Jan 2021 — Feb 2021 [monthly]

Not Yet Recruiting NA

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

National Cancer Institute, Slovakia
Slovak Academy of Sciences

Data source: National Cancer Institute, Slovakia

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Bratislava, Slovakia